40 results on '"Papa, Sophie"'
Search Results
2. Proceedings of the inaugural Dark Genome Symposium: November 2022
3. Acute kidney injury in patients treated with immune checkpoint inhibitors
4. Pre-treatment with systemic agents for advanced NSCLC elicits changes in the phenotype of autologous T cell therapy products
5. Lifileucel, an Autologous Tumor-infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors
6. Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma
7. Differences between immunotherapy-induced and primary hypophysitis—a multicenter retrospective study
8. Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade
9. Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity
10. Association between COVID-19 burden and delays to diagnosis and treatment of cancer patients in England
11. Metabolic armouring of CAR and TCR T cells
12. A call to adapt the regulation of HLA testing for T cell receptor-based therapeutics
13. 362 Allelic variants of MR1 drive cancer and allo-reactivity by MR1-restricted T cells
14. Optimal selection of tumor antigens
15. Conserved allomorphs of MR1 drive specificity of MR1-restricted TCRs
16. Intratumoral pan-ErbB targeted CAR-T for head and neck squamous cell carcinoma: interim analysis of the T4 immunotherapy study
17. The threat of triple M and autoimmune overlap syndromes with immune checkpoint inhibitors - A series of case reports
18. A rapidly expanding cutaneous tumour in the context of a Janus kinase inhibitor agent following allogeneic stem cell transplant
19. Papulonodular pigmented lesions in a patient with Stage IV malignant melanoma
20. Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis
21. Safe delivery of systemic anti‐cancer treatment for skin cancers during the COVID ‐19 pandemic
22. 18F FDG PET/CT and Novel Molecular Imaging for Directing Immunotherapy in Cancer
23. CDK Inhibition Primes for Anti-PD-L1 Treatment in Triple-Negative Breast Cancer Models
24. Immune checkpoint inhibitor‐related cholangiopathy: Novel clinicopathological description of a multi‐centre cohort
25. Safe delivery of systemic anti‐cancer treatment for skin cancers during the COVID‐19 pandemic.
26. Immune checkpoint inhibitor‐related cholangiopathy: Novel clinicopathological description of a multi‐centre cohort.
27. BRAF inhibitors and their immunological effects in malignant melanoma
28. The Impact of COVID-19 on the Delivery of Systemic Anti-Cancer Treatment at Guy’s Cancer Centre
29. Understanding the Lived Experiences of Patients With Melanoma: Real-World Evidence Generated Through a European Social Media Listening Analysis (Preprint)
30. PMO-47 Clipper (Beclomethasone Dipropionate) as a treatment for checkpoint inhibitor induced enterocolitis
31. 458 First phase 2 results of autologous tumor-infiltrating lymphocyte (TIL; LN-145) monotherapy in patients with advanced, immune checkpoint inhibitor-treated, non-small cell lung cancer (NSCLC)
32. ATU-2 A multi-centre study of Infliximab treatment for corticosteroid-refractory Checkpoint Inhibitor Induced enterocolitis
33. Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer
34. Differences between immunotherapy-induced and primary hypophysitis—a multicenter retrospective study
35. Understanding the Lived Experiences of Patients With Melanoma: Real-World Evidence Generated Through a European Social Media Listening Analysis.
36. Papulonodular pigmented lesions in a patient with Stage IV malignant melanoma.
37. Risk of COVID-19 death in cancer patients: an analysis from Guy's Cancer Centre and King's College Hospital in London.
38. Engineering T cell metabolism for enhanced CAR T cell efficacy
39. Pre-treatment with systemic agents for advanced NSCLC elicits changes in the phenotype of autologous T cell therapy products.
40. 18 F FDG PET/CT and Novel Molecular Imaging for Directing Immunotherapy in Cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.